HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries.
Saved in:
| Title: | HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries. |
|---|---|
| Authors: | Dhalla, S. (AUTHOR), Woods, R. (AUTHOR), Strathdee, S. A. (AUTHOR), Patrick, D. M. (AUTHOR), Hogg, R. S. (AUTHOR) |
| Source: | AIDS Care. Oct2007, Vol. 19 Issue 9, p1118-1127. 10p. 2 Charts, 2 Graphs. |
| Subjects: | Clinical trials, Drug development, AIDS vaccines, AIDS prevention, HIV infections, Therapeutics, Preventive medicine, Medical care, HIV-positive persons, Organisation for Economic Co-operation & Development |
| Abstract: | HIV vaccine development remains an urgent priority. This article is a systematic review of HIV vaccine preparedness studies in the high-income 30 Organization for Economic Co-operation and Development countries, to identify factors important for HIV vaccine trial development in injection drug users (IDU), men who have sex with men (MSM), and women at heterosexual risk (WAHR) across these countries. Of 27 articles we identified, willingness to participate (WTP) was assessed in eight studies involving IDU, 11 involving MSM, and one involving WAHR. WTP ranged in IDU at 41-86%, MSM at 23-94%, and in WAHR, it was at 81%. Studies reported recruitment of high-risk individuals. Retention was assessed in eight studies involving IDU, five involving MSM, and three involving WAHR. IDU were retained at a range of 3-98%, MSM at 70-95% and WAHR at 67-92%. This review provides an in-depth summary of HIV vaccine preparedness studies that were conducted in the Organization for Economic Co-operation and Development countries. [ABSTRACT FROM AUTHOR] |
| Copyright of AIDS Care is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 27754203 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Dhalla%2C+S%2E%22">Dhalla, S.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Woods%2C+R%2E%22">Woods, R.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Strathdee%2C+S%2E+A%2E%22">Strathdee, S. A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Patrick%2C+D%2E+M%2E%22">Patrick, D. M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hogg%2C+R%2E+S%2E%22">Hogg, R. S.</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22AIDS+Care%22">AIDS Care</searchLink>. Oct2007, Vol. 19 Issue 9, p1118-1127. 10p. 2 Charts, 2 Graphs. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Clinical+trials%22">Clinical trials</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+development%22">Drug development</searchLink><br /><searchLink fieldCode="DE" term="%22AIDS+vaccines%22">AIDS vaccines</searchLink><br /><searchLink fieldCode="DE" term="%22AIDS+prevention%22">AIDS prevention</searchLink><br /><searchLink fieldCode="DE" term="%22HIV+infections%22">HIV infections</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink><br /><searchLink fieldCode="DE" term="%22Preventive+medicine%22">Preventive medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+care%22">Medical care</searchLink><br /><searchLink fieldCode="DE" term="%22HIV-positive+persons%22">HIV-positive persons</searchLink><br /><searchLink fieldCode="DE" term="%22Organisation+for+Economic+Co-operation+%26+Development%22">Organisation for Economic Co-operation & Development</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: HIV vaccine development remains an urgent priority. This article is a systematic review of HIV vaccine preparedness studies in the high-income 30 Organization for Economic Co-operation and Development countries, to identify factors important for HIV vaccine trial development in injection drug users (IDU), men who have sex with men (MSM), and women at heterosexual risk (WAHR) across these countries. Of 27 articles we identified, willingness to participate (WTP) was assessed in eight studies involving IDU, 11 involving MSM, and one involving WAHR. WTP ranged in IDU at 41-86%, MSM at 23-94%, and in WAHR, it was at 81%. Studies reported recruitment of high-risk individuals. Retention was assessed in eight studies involving IDU, five involving MSM, and three involving WAHR. IDU were retained at a range of 3-98%, MSM at 70-95% and WAHR at 67-92%. This review provides an in-depth summary of HIV vaccine preparedness studies that were conducted in the Organization for Economic Co-operation and Development countries. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of AIDS Care is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=27754203 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/09540120701352258 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1118 Subjects: – SubjectFull: Clinical trials Type: general – SubjectFull: Drug development Type: general – SubjectFull: AIDS vaccines Type: general – SubjectFull: AIDS prevention Type: general – SubjectFull: HIV infections Type: general – SubjectFull: Therapeutics Type: general – SubjectFull: Preventive medicine Type: general – SubjectFull: Medical care Type: general – SubjectFull: HIV-positive persons Type: general – SubjectFull: Organisation for Economic Co-operation & Development Type: general Titles: – TitleFull: HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dhalla, S. – PersonEntity: Name: NameFull: Woods, R. – PersonEntity: Name: NameFull: Strathdee, S. A. – PersonEntity: Name: NameFull: Patrick, D. M. – PersonEntity: Name: NameFull: Hogg, R. S. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: Oct2007 Type: published Y: 2007 Identifiers: – Type: issn-print Value: 09540121 Numbering: – Type: volume Value: 19 – Type: issue Value: 9 Titles: – TitleFull: AIDS Care Type: main |
| ResultId | 1 |